Mimio Health Announces Breakthrough Clinical Trial Of Its Fasting Mimetic, Demonstrating Fasting-Like Benefits Without Dietary Changes

MimioHealth, an award-winning nutraceutical company developing biomimetic products designed from human biology to optimize cellular function, boost performance, and support longevity, today announced ...
Psychology Today

On Diagnosis and Formulation

Diagnosis determines what illness is present; formulation explains why it takes its particular form in a given person. Both ...
The Manila Times

BreezeMeds GLP-1 Weight Loss 2026: Compounded Semaglutide and Tirzepatide Pricing (From $199), FDA Regulatory Status Examined

A 2026 Informational Overview of the BreezeMeds Compounded GLP-1 Telehealth Weight Loss Platform, Semaglutide and Tirzepatide Medication Formats, Published Pricing Structure, 503A Compounding Pharmacy ...

Blue CPR Emerges as Clinical Performance Leader in Korea’s Competitive Derma-Skincare Market

SEOUL, SOUTH KOREA, February 27, 2026 / EINPresswire.com / — Blue CPR, a Korean advanced derma-skincare brand combining scientific formulation with clinical dermatological insights, is gaining ...
The Manila Times

SkinnyRx GLP-1 Weight Loss 2026: Compounded Semaglutide and Tirzepatide Program, Pricing, and FDA Regulatory Status Examined

Examining SkinnyRx's Compounded GLP-1 Weight Loss Platform for 2026: Semaglutide and Tirzepatide Medication Formats, Subscription Pricing From $199 Per Month, 503A Pharmacy Sourcing, Clinical Research ...

Definium Therapeutics Q4 Earnings Call Highlights

Definium Therapeutics (NASDAQ:DFTX) used its full-year 2025 earnings call to highlight impending late-stage clinical ...

Introducing a Non-Stim Pre Workout for Enhanced Vascularity

Revolutionary Liquid Pump Product for Optimal Performance Tempe, Aruba - February 25, 2026 / Performance Supplements / ...
The Lancet

Antipsychotic medicines for schizophrenia: time to move forward

Antipsychotic medicines are a key part of the pharmacological treatment of schizophrenia. Although they provide therapeutic ...

NanOlogy, LLC CEO David J. Arthur Discusses Their PURCISION™ Technology Advancing Intratumoral Therapy to Treat Cancer

CEOCFO interviews NanOlogy, LLC CEO David J. Arthur on Solving Toxicity & Bioavailability Problems when Treating ...

Curium Announces Pharmacokinetics and Dosimetry Data for Investigational Lutetium-177 Zadavotide Guraxetan in Metastatic Castration-Resistant Prostate Cancer at ASCO GU 2026

Dosimetry data from the Phase 3 ECLIPSE substudy demonstrated favorable organ radiation absorbed doses supporting administration of 7.4 GBq for up to six cycles BOSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) ...

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be available this spring.
Institute of Food Technologists

How GLP-1 Adoption Is Shaping Formulation Strategies

As GLP-1 adoption reshapes appetite, satiety, and purchasing patterns, food and beverage manufacturers are reassessing formulation strategies. In this Q&A, Tate & Lyle’s Jenna Peterson discusses ...